- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 2, 2025 | 32.13M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $403.1M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $447.83M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $183.96M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $123.51M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $200.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $207.52M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $313.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $335.99M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.11B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.12B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.34B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.35B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 32.93M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $15M |
| Capex | Q1 2025 · Mar 31, 2024 | $1.62M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $42.22M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $901.74M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $864.88M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.57 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.58 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $16.41M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $25.66M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $56.54M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $116.05M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $136.32M |
| Revenue | Q1 2025 · Mar 31, 2024 | $252.37M |